Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - allopurinol 300mg;  ;   - tablet - 300 mg - active: allopurinol 300mg     excipient: lactose monohydrate magnesium stearate maize starch povidone

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - allopurinol 100mg;  ;   - tablet - 100 mg - active: allopurinol 100mg     excipient: lactose monohydrate magnesium stearate maize starch povidone

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

viatris limited - eptifibatide 0.75 mg/ml (75 mg in 100 ml) - solution for infusion - 0.75 mg/ml - active: eptifibatide 0.75 mg/ml (75 mg in 100 ml) excipient: citric acid monohydrate sodium hydroxide water for injection - indicated for patients undergoing non-urgent, percutaneous coronary intervention (pci) with coronary stenting for the reduction of death, myocardial infarction, urgent revascularisation and the need for acute antithrombotic rescue therapy. indicated for the reduction of death and myocardial infarction in patients presenting with unstable angina or non-q-wave myocardial infarction. indicated in patients who are managed with standard medical therapies and/or with percutaneous coronary intervention. eptifibatide is intended for use with aspirin, heparin or clopidigrel.

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

viatris limited - eptifibatide 2 mg/ml (20 mg in 10 ml) - solution for injection - 2 mg/ml - active: eptifibatide 2 mg/ml (20 mg in 10 ml) excipient: citric acid monohydrate sodium hydroxide water for injection - indicated for patients undergoing non-urgent, percutaneous coronary intervention (pci) with coronary stenting for the reduction of death, myocardial infarction, urgent revascularisation and the need for acute antithrombotic rescue therapy. indicated for the reduction of death and myocardial infarction in patients presenting with unstable angina or non-q-wave myocardial infarction. indicated in patients who are managed with standard medical therapies and/or with percutaneous coronary intervention. eptifibatide is intended for use with aspirin, heparin or clopidigrel.

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - glatiramer acetate 40 mg/ml;  ;   - solution for injection - 40 mg/ml - active: glatiramer acetate 40 mg/ml     excipient: mannitol water for injection - reduction of the frequency of relapses in patients with relapsing remitting multiple sclerosis. treatment of patients with a single clinical event suggestive of multiple sclerosis and at least two clinically silent mri lesions characteristic of multiple sclerosis, if alternative diagnoses have been excluded.

Jordaania - inglise - JFDA (Jordan Food & Drug Administration - المؤسسة العامة للغذاء والدواء)

مستودع خوري - khoury drug store - potassium sodium hydrogen citrate (6:6:3:5) 2.4 gm/2.5g - 2.4 gm/2.5g

Kanada - inglise - Health Canada

novopharm limited - cefuroxime (cefuroxime axetil) - tablet - 125mg - cefuroxime (cefuroxime axetil) 125mg - second generation cephalosporins

Kanada - inglise - Health Canada

novopharm limited - cefuroxime (cefuroxime axetil) - tablet - 250mg - cefuroxime (cefuroxime axetil) 250mg - second generation cephalosporins

Kanada - inglise - Health Canada

novopharm limited - cefuroxime (cefuroxime axetil) - tablet - 500mg - cefuroxime (cefuroxime axetil) 500mg - second generation cephalosporins

Kanada - inglise - Health Canada

orbus pharma inc - cefuroxime (cefuroxime axetil) - tablet - 250mg - cefuroxime (cefuroxime axetil) 250mg - second generation cephalosporins